Answers are grounded in this paper and cite their sources.
The same CRISPR interference knockdown changes expression differently in different cell lines. Testing whether a gene-level feature such as chromatin accessibility explains these differences is difficult because neighbouring genes share regulatory elements and copy-number segments, so genes are not independent; in simulation, standard gene-level tests reached false-positive rates of up to 25.8% at a nominal 5% level. cdtest is a Python package that keeps the response fixed and permutes the feature in genome-ordered blocks, with chromosome-arm adjustment, noise-corrected response differences, test-inversion confidence intervals and planted-signal power benchmarks. On real outcomes it held the nominal level under a decoy-free null (4.9% at 5%), and all confirmatory results can be recomputed in under a minute from deposited intermediates. Applied to essential-gene screens in four human cell lines, it detected planted effects of 0.5% partial variance explained with at least 80% power in a matched pair, found no detectable accessibility effect in that pair, and flagged an association that depended on the choice of signal track.
No takes yet. Share an insight, caveat, or question.
Tharun H. Nambi (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: